JOSHUA RAPHAEL KORZENIK, M.D.
Osteopathic Medicine at Francis St, Boston, MA

License number
Massachusetts 72914
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address 2
75 Francis St, Boston, MA 02115
111 Cypress St, Brookline, MA 02445
Phone
(617) 732-5500
(857) 307-0896

Personal information

See more information about JOSHUA RAPHAEL KORZENIK at radaris.com
Name
Address
Phone
Joshua Korzenik, age 67
184 Pine Ridge Rd, Waban, MA 02468
Joshua R Korzenik, age 67
37 Miller Hill Rd, Dover, MA 02030
(774) 893-4130
Joshua R Korzenik, age 67
6 Fort Washington Pl, Cambridge, MA 02139
(617) 864-0434
Joshua R Korzenik
791 Tremont St, Boston, MA 02118

Professional information

See more information about JOSHUA RAPHAEL KORZENIK at trustoria.com
Joshua Raphael Korzenik Photo 1
Dr. Joshua Raphael Korzenik, Boston MA - MD (Doctor of Medicine)

Dr. Joshua Raphael Korzenik, Boston MA - MD (Doctor of Medicine)

Specialties:
Gastroenterology
Address:
MGH Crohn's Colitis Center
165 Cambridge St, Boston 02114
(617) 724-6005 (Phone)
Massachussetts General Hosp-GAS
55 Fruit St, Boston 02114
(617) 724-6005 (Phone)
Certifications:
Gastroenterology, 2009, Internal Medicine, 1990
Languages:
English
Hospitals:
MGH Crohn's Colitis Center
165 Cambridge St, Boston 02114
Massachussetts General Hosp-GAS
55 Fruit St, Boston 02114
Massachusetts General Hospital
55 Fruit St, Boston 02114
Education:
Medical School
Albert Einstein College Of Medicine Of Yeshiva University
Graduated: 1987
Beth Israel Deaconess Medical Center
Yale New Haven Hospital
Background:
Sanction:  1 time(s)


Joshua Korzenik Photo 2
Joshua Korzenik, Brookline MA

Joshua Korzenik, Brookline MA

Specialties:
Gastroenterologist
Address:
111 Cypress St, Brookline, MA 02445
75 Francis St, Boston, MA 02115
Education:
Yeshiva University, Albert Einstein College of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)


Joshua Korzenik Photo 3
Disruption Of The Reg Pathway

Disruption Of The Reg Pathway

US Patent:
2004024, Dec 2, 2004
Filed:
Apr 8, 2004
Appl. No.:
10/819991
Inventors:
Brian Dieckgraefe - Chesterfield MO, US
Joshua Korzenik - Boston MA, US
Assignee:
Washington University - St. Louis MO
International Classification:
A61K048/00, A61K031/415, A61K031/365
US Classification:
514/044000, 514/406000, 514/471000
Abstract:
Disruption of the Reg signalling pathway permits spontaneous and therapeutic induction of pro-apoptotic signals to be more effective. Disruption can be accomplished by means of antibodies, antisense, RNA interference, small molecule inhibitors, etc. These can be used in conjunction with conventional anti-neoplastic therapies. Inhibitors can be identified by assays that monitor the disruption of the binding of Reg ligands and the Reg ligand receptor.